What is the difference between First Analysis' buy, hold, and sell ratings?

Name: Community Performance Rating
Item: First Analysis
Rating: 2.6
Author: MarketBeat

First Analysis Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at First Analysis. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from First Analysis' equity research team. MarketBeat is not affiliated with or endorsed by First Analysis.

Updated 10/16/2020

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 0 Last 12 Months
Buy Ratings: 0 Last 12 Months
Sell Ratings: 0 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
ACET Adicet Bio	$7.26 -10.9%	10/16/2020		Downgrade		Hold	View details for First Analysis rating of Adicet Bio (NASDAQ:ACET) on 10/16/2020
DGII Digi International	$65.95 -4.8%	3/13/2020		Lower Price Target	$21.00 ➝ $19.00	Strong-Buy	View details for First Analysis rating of Digi International (NASDAQ:DGII) on 3/13/2020
BILL BILL	$35.98 +0.0%	3/10/2020		Initiated Coverage	$55.00	Outperform	View details for First Analysis rating of BILL (NYSE:BILL) on 3/10/2020
MIXT MiX Telematics	$14.55	3/9/2020		Downgrade	$21.00 ➝ $19.00	Strong-Buy ➝ Outperform	View details for First Analysis rating of MiX Telematics (NYSE:MIXT) on 3/9/2020
CHGG Chegg	$1.18 -6.7%	3/1/2020		Upgrade	$48.00	Outperform ➝ Strong-Buy	View details for First Analysis rating of Chegg (NYSE:CHGG) on 3/1/2020
NEO NeoGenomics	$10.90 -3.6%	2/28/2020		Upgrade	$35.00	Outperform ➝ Strong-Buy	View details for First Analysis rating of NeoGenomics (NASDAQ:NEO) on 2/28/2020
RAMP LiveRamp	$37.43 +0.1%	1/26/2020	David Gearhart Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$63.00	Buy	View details for First Analysis rating of LiveRamp (NYSE:RAMP) on 1/26/2020
NEO NeoGenomics	$10.90 -3.6%	1/23/2020		Downgrade	$29.00 ➝ $35.00	Strong-Buy ➝ Outperform	View details for First Analysis rating of NeoGenomics (NASDAQ:NEO) on 1/23/2020
SPSC SPS Commerce	$55.47 -1.1%	1/16/2020		Boost Price Target	$61.00 ➝ $68.00	Strong-Buy	View details for First Analysis rating of SPS Commerce (NASDAQ:SPSC) on 1/16/2020
CHKP Check Point Software Technologies	$135.82 -0.5%	1/14/2020		Downgrade	$133.00 ➝ $119.00	Outperform ➝ Neutral	View details for First Analysis rating of Check Point Software Technologies (NASDAQ:CHKP) on 1/14/2020
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
PANW Palo Alto Networks	$272.05 -2.6%	1/14/2020		Downgrade	$49.17 ➝ $48.33	Strong-Buy ➝ Outperform	View details for First Analysis rating of Palo Alto Networks (NASDAQ:PANW) on 1/14/2020
ANIK Anika Therapeutics	$14.48 -2.1%	1/10/2020	Joseph Munda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$65.00	Outperform ➝ Strong-Buy	View details for First Analysis rating of Anika Therapeutics (NASDAQ:ANIK) on 1/10/2020
DGII Digi International	$65.95 -4.8%	1/8/2020		Boost Price Target	$20.00 ➝ $21.00	Strong-Buy	View details for First Analysis rating of Digi International (NASDAQ:DGII) on 1/8/2020
CAMP CAMP4 Therapeutics	$4.11 -4.4%	12/20/2019		Downgrade	$391.00 ➝ $276.00	Outperform ➝ Neutral	View details for First Analysis rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 12/20/2019
RGEN Repligen	$122.31 -3.4%	11/1/2019		Upgrade	$107.00 ➝ $110.00	Outperform ➝ Strong-Buy	View details for First Analysis rating of Repligen (NASDAQ:RGEN) on 11/1/2019
UPWK Upwork	$8.76 +0.2%	10/31/2019		Initiated Coverage	$18.00	Outperform	View details for First Analysis rating of Upwork (NASDAQ:UPWK) on 10/31/2019
SPSC SPS Commerce	$55.47 -1.1%	10/25/2019	David Gearhart Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Outperform ➝ Strong-Buy	View details for First Analysis rating of SPS Commerce (NASDAQ:SPSC) on 10/25/2019
LMAT LeMaitre Vascular	$94.48 +1.0%	10/24/2019		Downgrade	$37.00 ➝ $40.00	Strong-Buy ➝ Outperform	View details for First Analysis rating of LeMaitre Vascular (NASDAQ:LMAT) on 10/24/2019
ALRM Alarm.com	$45.37 +0.8%	10/21/2019		Upgrade	$75.00	Outperform ➝ Strong-Buy	View details for First Analysis rating of Alarm.com (NASDAQ:ALRM) on 10/21/2019
LMAT LeMaitre Vascular	$94.48 +1.0%	10/14/2019		Upgrade	$37.00	Outperform ➝ Strong-Buy	View details for First Analysis rating of LeMaitre Vascular (NASDAQ:LMAT) on 10/14/2019
BL BlackLine	$28.66 -0.2%	10/4/2019		Initiated Coverage	$55.00	Outperform	View details for First Analysis rating of BlackLine (NASDAQ:BL) on 10/4/2019
ANIK Anika Therapeutics	$14.48 -2.1%	9/23/2019		Downgrade	$54.00	Strong-Buy ➝ Outperform	View details for First Analysis rating of Anika Therapeutics (NASDAQ:ANIK) on 9/23/2019
RAMP LiveRamp	$37.43 +0.1%	9/20/2019		Upgrade		Outperform ➝ Strong-Buy	View details for First Analysis rating of LiveRamp (NYSE:RAMP) on 9/20/2019
BOX BOX	$26.67 -0.4%	8/29/2019		Downgrade	$22.00 ➝ $14.00	Outperform ➝ Neutral	View details for First Analysis rating of BOX (NYSE:BOX) on 8/29/2019
RGEN Repligen	$122.31 -3.4%	8/28/2019		Boost Price Target	$95.00 ➝ $107.00	Outperform	View details for First Analysis rating of Repligen (NASDAQ:RGEN) on 8/28/2019
EHTH eHealth	$1.73 +9.5%	7/29/2019	Frank Sparacino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$106.00 ➝ $136.00	Outperform ➝ Strong-Buy	View details for First Analysis rating of eHealth (NASDAQ:EHTH) on 7/29/2019
ANIK Anika Therapeutics	$14.48 -2.1%	7/25/2019		Upgrade	$37.00 ➝ $54.00	Neutral ➝ Strong-Buy	View details for First Analysis rating of Anika Therapeutics (NASDAQ:ANIK) on 7/25/2019
LMAT LeMaitre Vascular	$94.48 +1.0%	7/25/2019		Upgrade	$29.00 ➝ $37.00	Neutral ➝ Outperform	View details for First Analysis rating of LeMaitre Vascular (NASDAQ:LMAT) on 7/25/2019
EHTH eHealth	$1.73 +9.5%	7/19/2019		Initiated Coverage	$106.00	Outperform	View details for First Analysis rating of eHealth (NASDAQ:EHTH) on 7/19/2019
STRA Strategic Education	$81.58 +1.3%	6/28/2019		Reiterated Rating	$210.00 ➝ $216.00	Strong-Buy	View details for First Analysis rating of Strategic Education (NASDAQ:STRA) on 6/28/2019
RAMP LiveRamp	$37.43 +0.1%	5/29/2019		Upgrade	$55.00	Neutral ➝ Outperform	View details for First Analysis rating of LiveRamp (NYSE:RAMP) on 5/29/2019
ALRM Alarm.com	$45.37 +0.8%	5/10/2019		Downgrade	$70.00 ➝ $75.00	Strong-Buy ➝ Outperform	View details for First Analysis rating of Alarm.com (NASDAQ:ALRM) on 5/10/2019
SPSC SPS Commerce	$55.47 -1.1%	4/26/2019		Upgrade		Neutral ➝ Outperform	View details for First Analysis rating of SPS Commerce (NASDAQ:SPSC) on 4/26/2019
ANIK Anika Therapeutics	$14.48 -2.1%	2/22/2019		Downgrade	$41.00 ➝ $37.00	Outperform ➝ Neutral	View details for First Analysis rating of Anika Therapeutics (NASDAQ:ANIK) on 2/22/2019
FTNT Fortinet	$144.68 -3.3%	2/8/2019		Upgrade	$16.00 ➝ $18.40	Neutral ➝ Outperform	View details for First Analysis rating of Fortinet (NASDAQ:FTNT) on 2/8/2019
CDXS Codexis	$2.56 -8.6%	1/17/2019		Upgrade	$12.00 ➝ $19.00	Neutral ➝ Outperform	View details for First Analysis rating of Codexis (NASDAQ:CDXS) on 1/17/2019
CAMP CAMP4 Therapeutics	$4.11 -4.4%	12/11/2018	Howard Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$667.00 ➝ $506.00	Strong-Buy ➝ Outperform	View details for First Analysis rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 12/11/2018
PANW Palo Alto Networks	$272.05 -2.6%	12/9/2018		Upgrade	$29.50	Outperform ➝ Strong-Buy	View details for First Analysis rating of Palo Alto Networks (NASDAQ:PANW) on 12/9/2018
PANW Palo Alto Networks	$272.05 -2.6%	11/30/2018		Upgrade	$40.00	Outperform ➝ Strong-Buy	View details for First Analysis rating of Palo Alto Networks (NASDAQ:PANW) on 11/30/2018
CHGG Chegg	$1.18 -6.7%	10/30/2018		Upgrade	$30.00	Neutral ➝ Outperform	View details for First Analysis rating of Chegg (NYSE:CHGG) on 10/30/2018
Trump's gold order: the announcement they won't put on the front page (Ad) On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. Request the free guide in 30 seconds and get positioned now
CAMP CAMP4 Therapeutics	$4.11 -4.4%	10/28/2018	Howard Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$667.00	Buy	View details for First Analysis rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 10/28/2018
SPSC SPS Commerce	$55.47 -1.1%	10/4/2018	David Gearhart Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$34.50 ➝ $43.00	Neutral	View details for First Analysis rating of SPS Commerce (NASDAQ:SPSC) on 10/4/2018
NEO NeoGenomics	$10.90 -3.6%	9/18/2018	Joseph Munda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$16.00	Buy	View details for First Analysis rating of NeoGenomics (NASDAQ:NEO) on 9/18/2018
QLYS Qualys	$109.90 -1.5%	9/10/2018	Howard Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$112.00	Buy	View details for First Analysis rating of Qualys (NASDAQ:QLYS) on 9/10/2018
NSP Insperity	$35.38 +5.7%	8/2/2018	James MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Overweight ➝ Equal Weight	View details for First Analysis rating of Insperity (NYSE:NSP) on 8/2/2018
NSP Insperity	$35.38 +5.7%	8/1/2018		Downgrade	$102.00	Overweight ➝ Equal Weight	View details for First Analysis rating of Insperity (NYSE:NSP) on 8/1/2018
BOX BOX	$26.67 -0.4%	7/20/2018		Initiated Coverage	$32.00	Overweight	View details for First Analysis rating of BOX (NYSE:BOX) on 7/20/2018
CAMP CAMP4 Therapeutics	$4.11 -4.4%	7/5/2018	Howard Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$667.00	Buy	View details for First Analysis rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 7/5/2018
DGII Digi International	$65.95 -4.8%	7/5/2018	David Gearhart Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$16.00	Buy	View details for First Analysis rating of Digi International (NASDAQ:DGII) on 7/5/2018
ANIK Anika Therapeutics	$14.48 -2.1%	6/20/2018	Joseph Munda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$45.00 ➝ $34.00	Overweight ➝ Equal Weight	View details for First Analysis rating of Anika Therapeutics (NASDAQ:ANIK) on 6/20/2018
QLYS Qualys	$109.90 -1.5%	6/14/2018		Upgrade	$82.00 ➝ $110.00	Equal Weight ➝ Overweight	View details for First Analysis rating of Qualys (NASDAQ:QLYS) on 6/14/2018
INTU Intuit	$296.76 -1.7%	5/23/2018		Downgrade	$143.00 ➝ $160.00	Equal ➝ Sell	View details for First Analysis rating of Intuit (NASDAQ:INTU) on 5/23/2018
MMS Maximus	$60.49 0.0%	5/8/2018		Upgrade	$73.00 ➝ $81.00	Equal ➝ Equal Weight	View details for First Analysis rating of Maximus (NYSE:MMS) on 5/8/2018
NEO NeoGenomics	$10.90 -3.6%	5/2/2018	Joseph Munda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$11.00	Overweight ➝ Equal Weight	View details for First Analysis rating of NeoGenomics (NASDAQ:NEO) on 5/2/2018
PAYC Paycom Software	$137.65 +0.4%	5/2/2018	Corey Greendale Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$108.00 ➝ $122.00	Overweight ➝ Equal Weight	View details for First Analysis rating of Paycom Software (NYSE:PAYC) on 5/2/2018
ALRM Alarm.com	$45.37 +0.8%	4/17/2018	Howard Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$52.00	Buy	View details for First Analysis rating of Alarm.com (NASDAQ:ALRM) on 4/17/2018
PCTY Paylocity	$113.46 +0.7%	3/19/2018		Boost Price Target	$63.00 ➝ $65.00	Overweight	View details for First Analysis rating of Paylocity (NASDAQ:PCTY) on 3/19/2018
STRA Strategic Education	$81.58 +1.3%	3/4/2018		Upgrade	$105.00 ➝ $112.00	Equal Weight ➝ Overweight	View details for First Analysis rating of Strategic Education (NASDAQ:STRA) on 3/4/2018
QLYS Qualys	$109.90 -1.5%	2/23/2018		Reiterated Rating	$70.00 ➝ $80.00	Equal ➝ Equal Weight	View details for First Analysis rating of Qualys (NASDAQ:QLYS) on 2/23/2018
CAMP CAMP4 Therapeutics	$4.11 -4.4%	2/16/2018		Upgrade	$667.00	Equal Weight ➝ Overweight	View details for First Analysis rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 2/16/2018
ILMN Illumina	$162.32 -3.4%	1/31/2018		Upgrade	$277.00	Equal Weight ➝ Overweight	View details for First Analysis rating of Illumina (NASDAQ:ILMN) on 1/31/2018
ANIK Anika Therapeutics	$14.48 -2.1%	1/24/2018		Upgrade	$45.00 ➝ $68.00	Equal Weight ➝ Overweight	View details for First Analysis rating of Anika Therapeutics (NASDAQ:ANIK) on 1/24/2018
PACB Pacific Biosciences of California	$1.45 -11.0%	11/3/2017		Downgrade	$4.00	Overweight ➝ Equal Weight	View details for First Analysis rating of Pacific Biosciences of California (NASDAQ:PACB) on 11/3/2017
CHGG Chegg	$1.18 -6.7%	10/31/2017		Downgrade	$18.00	Overweight ➝ Equal Weight	View details for First Analysis rating of Chegg (NYSE:CHGG) on 10/31/2017
LMAT LeMaitre Vascular	$94.48 +1.0%	10/27/2017		Downgrade	$34.00	Overweight ➝ Equal Weight	View details for First Analysis rating of LeMaitre Vascular (NASDAQ:LMAT) on 10/27/2017
ATEK Athena Technology Acquisition	$9.50	10/23/2017	Frank Sparacino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$125.00 ➝ $127.00	Underweight ➝ Equal Weight	View details for First Analysis rating of Athena Technology Acquisition (OTCMKTS:ATEK) on 10/23/2017
RGEN Repligen	$122.31 -3.4%	10/2/2017		Upgrade	$47.00	Equal Weight ➝ Overweight	View details for First Analysis rating of Repligen (NASDAQ:RGEN) on 10/2/2017
PANW Palo Alto Networks	$272.05 -2.6%	9/1/2017		Upgrade	$26.67	Equal Weight ➝ Overweight	View details for First Analysis rating of Palo Alto Networks (NASDAQ:PANW) on 9/1/2017
INTU Intuit	$296.76 -1.7%	8/23/2017		Upgrade	$128.00	Underweight ➝ Equal Weight	View details for First Analysis rating of Intuit (NASDAQ:INTU) on 8/23/2017
ILMN Illumina	$162.32 -3.4%	8/2/2017	Joseph Munda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$176.00	Underweight ➝ Equal Weight	View details for First Analysis rating of Illumina (NASDAQ:ILMN) on 8/2/2017
MSTR Strategy	$120.44 -6.9%	7/31/2017	Frank Sparacino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$22.50 ➝ $14.00	Overweight ➝ Equal Weight	View details for First Analysis rating of Strategy (NASDAQ:MSTR) on 7/31/2017
HSTM HealthStream	$25.24 -0.2%	7/26/2017		Upgrade	$19.00	Underweight ➝ Equal Weight	View details for First Analysis rating of HealthStream (NASDAQ:HSTM) on 7/26/2017
ATEK Athena Technology Acquisition	$9.50	7/24/2017		Downgrade	$99.00 ➝ $125.00	Equal Weight ➝ Underweight	View details for First Analysis rating of Athena Technology Acquisition (OTCMKTS:ATEK) on 7/24/2017
MDXG MiMedx Group	$3.74 -1.1%	5/23/2017	Joseph Munda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$11.00	Equal Weight ➝ Underweight	View details for First Analysis rating of MiMedx Group (NASDAQ:MDXG) on 5/23/2017
CHGG Chegg	$1.18 -6.7%	5/22/2017		Boost Price Target	$12.00 ➝ $14.00	Overweight	View details for First Analysis rating of Chegg (NYSE:CHGG) on 5/22/2017
STRA Strategic Education	$81.58 +1.3%	5/15/2017		Boost Price Target	$76.00 ➝ $95.00	Equal ➝ Equal Weight	View details for First Analysis rating of Strategic Education (NASDAQ:STRA) on 5/15/2017
RGEN Repligen	$122.31 -3.4%	4/21/2017		Reiterated Rating	$40.00	Equal Weight	View details for First Analysis rating of Repligen (NASDAQ:RGEN) on 4/21/2017
LMAT LeMaitre Vascular	$94.48 +1.0%	3/21/2017		Initiated Coverage	$29.00	Overweight	View details for First Analysis rating of LeMaitre Vascular (NASDAQ:LMAT) on 3/21/2017
PANW Palo Alto Networks	$272.05 -2.6%	3/1/2017		Downgrade	$29.17 ➝ $20.00	Overweight ➝ Equal Weight	View details for First Analysis rating of Palo Alto Networks (NASDAQ:PANW) on 3/1/2017
NRC National Research	$19.14 -3.1%	2/16/2017		Reiterated Rating	$45.00 ➝ $44.00	Overweight ➝ Equal Weight	View details for First Analysis rating of National Research (NASDAQ:NRC) on 2/16/2017
NSP Insperity	$35.38 +5.7%	2/13/2017		Upgrade	$42.00 ➝ $49.00	Equal Weight ➝ Overweight	View details for First Analysis rating of Insperity (NYSE:NSP) on 2/13/2017
QLYS Qualys	$109.90 -1.5%	2/9/2017		Downgrade	$42.00 ➝ $37.00	Overweight ➝ Equal Weight	View details for First Analysis rating of Qualys (NASDAQ:QLYS) on 2/9/2017
ACET Adicet Bio	$7.26 -10.9%	1/31/2017		Downgrade		Overweight ➝ Equal Weight	View details for First Analysis rating of Adicet Bio (NASDAQ:ACET) on 1/31/2017
CDXS Codexis	$2.56 -8.6%	1/26/2017		Downgrade	$5.50	Overweight ➝ Equal Weight	View details for First Analysis rating of Codexis (NASDAQ:CDXS) on 1/26/2017
HSTM HealthStream	$25.24 -0.2%	1/23/2017	Frank Sparacino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$24.00 ➝ $18.00	Equal Weight ➝ Underweight	View details for First Analysis rating of HealthStream (NASDAQ:HSTM) on 1/23/2017
CHKP Check Point Software Technologies	$135.82 -0.5%	1/20/2017		Upgrade	$116.00	Equal Weight ➝ Overweight	View details for First Analysis rating of Check Point Software Technologies (NASDAQ:CHKP) on 1/20/2017
MDXG MiMedx Group	$3.74 -1.1%	12/12/2016	Joseph Munda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Hold	View details for First Analysis rating of MiMedx Group (NASDAQ:MDXG) on 12/12/2016
CWST Casella Waste Systems	$85.90 +2.7%	12/9/2016		Downgrade	$14.00 ➝ $15.00	Overweight ➝ Equal Weight	View details for First Analysis rating of Casella Waste Systems (NASDAQ:CWST) on 12/9/2016
ACET Adicet Bio	$7.26 -10.9%	11/14/2016		Downgrade	$368.00 ➝ $336.00	Overweight ➝ Equal Weight	View details for First Analysis rating of Adicet Bio (NASDAQ:ACET) on 11/14/2016
PCTY Paylocity	$113.46 +0.7%	11/4/2016	Corey Greendale Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$48.00	Equal Weight ➝ Overweight	View details for First Analysis rating of Paylocity (NASDAQ:PCTY) on 11/4/2016
Read this warning immediately (Ad) Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift. Read Porter Stansberry's full breakdown and protect your wealth now
ILMN Illumina	$162.32 -3.4%	11/2/2016		Downgrade	$130.00 ➝ $116.00	Equal Weight ➝ Underweight	View details for First Analysis rating of Illumina (NASDAQ:ILMN) on 11/2/2016
FTNT Fortinet	$144.68 -3.3%	10/21/2016		Initiated Coverage	$6.40	Equal ➝ Equal Weight	View details for First Analysis rating of Fortinet (NASDAQ:FTNT) on 10/21/2016
NEO NeoGenomics	$10.90 -3.6%	10/3/2016		Initiated Coverage	$11.00	Overweight	View details for First Analysis rating of NeoGenomics (NASDAQ:NEO) on 10/3/2016
CAMP CAMP4 Therapeutics	$4.11 -4.4%	9/30/2016		Downgrade	$437.00 ➝ $368.00	Overweight ➝ Equal Weight	View details for First Analysis rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 9/30/2016
SPSC SPS Commerce	$55.47 -1.1%	9/26/2016		Initiated Coverage	$43.00	Overweight	View details for First Analysis rating of SPS Commerce (NASDAQ:SPSC) on 9/26/2016
QLYS Qualys	$109.90 -1.5%	9/12/2016		Boost Price Target	$36.00 ➝ $41.00	Overweight	View details for First Analysis rating of Qualys (NASDAQ:QLYS) on 9/12/2016
WDAY Workday	$144.28 -2.5%	8/25/2016		Downgrade	$87.00 ➝ $88.00	Overweight ➝ Equal Weight	View details for First Analysis rating of Workday (NASDAQ:WDAY) on 8/25/2016
CAMP CAMP4 Therapeutics	$4.11 -4.4%	8/15/2016		Lower Price Target	$483.00 ➝ $437.00	Overweight	View details for First Analysis rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 8/15/2016
LRN Stride	$99.97 -2.0%	8/10/2016		Upgrade	$14.00	Equal Weight ➝ Overweight	View details for First Analysis rating of Stride (NYSE:LRN) on 8/10/2016
CWST Casella Waste Systems	$85.90 +2.7%	8/8/2016		Boost Price Target	$9.50 ➝ $11.50	Overweight	View details for First Analysis rating of Casella Waste Systems (NASDAQ:CWST) on 8/8/2016

MarketBeat Community Rating for First Analysis

MarketBeat's community ratings are surveys of what our community members think about First Analysis and other research firms in the last 90 days. Vote "Outperform" if you believe First Analysis's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe First Analysis's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.

COMMUNITY RATINGS: 2.6out of 5 (last 90 days)
2.6 of 5 stars
OUTPERFORM VOTES: 22 Believe will outperform the market
UNDERPERFORM VOTES: 21 Believe will underperform the market

Best & Worst Calls

Best Call
0000.0%
NYSE:BILL
Initiated Coverage • Mar 10, 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
NASDAQ:NH
Initiated Coverage • Jun 27, 2016
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Similarly Rated Firms

First Analysis - Frequently Asked Questions

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. First Analysis uses Overweight, Equal Weight, and Underweight as their equivalents.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?